novo glp-1 Nordisk launches Wegovy weight-loss pill in US, triggering price war | Pharmaceuticals industry Novo Nordisk cuts GLP-1 prices
Description
Disponvel em: Acesso em: 17 set
doi: 10.1016/j.clinthera.2017.05.354 [DOI] [PubMed] [Google Scholar] 79
Insulin Secretion GLP-1 receptor agonists enhance insulin secretion in a glucose-dependent manner
The competitive landscape intensifies as pharmaceutical giants invest heavily in next-generation GLP-1 analogs with improved efficacy profiles
Reference: Self-reported side effects of semaglutide and tirzepatide in online communities by Neil K
